How to avoid false conclusions: FDA finalizes long-awaited guidance on multiple endpoints in clinical trials
The FDA on Thursday finalized guidance, first drafted in 2017, that will help sponsors better understand FDA’s thinking about the problems …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
